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Background/Purpose: The objectives of this study were to: (1) survey migraine diagnoses among neuro-
logical outpatients in Taiwan; (2) compare neurologists’ migraine diagnoses with the International
Classification of Headache Disorders 2nd Edition (ICHD-2) criteria; and (3) evaluate the diagnostic ability
of screening items on a patient migraine questionnaire.
Methods: This prospective study surveyed patients who consulted neurologists for the first time with a chief
complaint of headache, excluding those experiencing headaches for ≥ 15 days/month. Each neurologist
interviewed a maximum of 10 patients. Patients were asked to complete a self-administered questionnaire
and their physicians completed another questionnaire. The physicians were asked if patients could be di-
agnosed with migraine. In addition, a diagnosis of ICHD-2 migraine was made by the physician’s ques-
tionnaire through a computer-generated algorithm. In this study, migraine without aura (code 1.1) or migraine
with aura (code 1.2) were designated as “strict migraine”, and the combination of strict migraine and ICHD-2
probable migraine (code 1.6) as “any migraine”.
Results: Among 755 patients who were eligible for analysis, 537 (71%) were diagnosed as having “any mi-
graine”, 363 (48%) with “strict migraine”, and 451 (60%) with physician-diagnosed migraine. Among the
537 patients diagnosed as having “any migraine”, 308 patients (57%) had not been diagnosed by any
physician before. A moderate agreement (kappa statistic around 0.5) was found between the physicians’
diagnoses and ICHD-2 “strict migraine” or “any migraine”. In patients with ICHD-2 probable migraine
(n = 174), only 52% were diagnosed with migraine by our physicians. Nausea was the best single item for
predicting migraine diagnosis, while any combination of two items among nausea/vomiting, moderate or
severe pain and photophobia, provided the optimum screening tool.
Conclusion: Migraine was the most common headache diagnosis in the neurologists’ clinics. Probable
migraine was not completely adopted as a migraine spectrum among neurologists. In contrast to ID
MigraineTM, moderate or severe headache intensity replaced headache-related disability as one screening
item for migraine in Taiwan. [J Formos Med Assoc 2008;107(6):485–494]
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ORIGINAL ARTICLE
Migraine is a common, disabling illness which
remains under-recognized, under-diagnosed and
under-treated in routine clinical practice.1–3 A re-
cent Landmark Study conducted in America and
Europe4 revealed that 82% of patients were diag-
nosed with non-migraine headache, but among
them, 48% actually satisfied the International
Classification of Headache Disorders, 2nd edition
(ICHD-2) criteria5 for migraine and 34% fulfilled
the ICHD-2 criteria for probable migraine. The
misclassification of other headache types and the
lack of appropriate treatment significantly impact
on the daily activities, work and social functioning
of migraine sufferers.
Our previous survey in 19976 revealed a mi-
graine prevalence of 9.1% in Taiwan. The physi-
cian consultation rate was 54%, but the migraine
diagnosis rate was relatively low (18%). The same
survey also revealed that only 12% of migraine
patients actually consulted a neurologist.7 In addi-
tion, a recent survey showed that Taiwanese neu-
rologists considered that patients with tension-type
headache were more common than those with mi-
graine (49.1% vs. 31.7%) in their outpatient clin-
ics.8 Now that more pharmacotherapeutic agents
are available, there is a need to increase migraine
awareness among patients and physicians. That
in turn points to the importance of developing 
a migraine screening tool to be used in clinics.
This study sought to determine how Taiwanese
neurologists diagnose migraine in their clinics,
and to develop a screening instrument which
might expedite physicians’ diagnoses of migraine.
Our objectives were to: (1) survey migraine diag-
noses among neurological outpatients; (2) com-
pare migraine diagnoses of neurologists with the
standard diagnostic criteria; and (3) evaluate the
migraine diagnostic ability of each screening
question or their combination.
Methods
Migraine Assessment for Prophylaxis (MAP)
The current study is part of the Migraine As-
sessment for Prophylaxis (MAP) program of the
Migraine Disability Awareness Campaign, which
was conducted in 2005. MAP is a multinational
survey of headache diagnosis among outpatients
attending neurological services. Eight countries in
Asia, including Taiwan, Korea, India, Thailand,
the Philippines, Malaysia, Hong Kong (China),
and Singapore participated in this study.
Patients
Male and female patients with a chief complaint
of headache, attending a neurological clinic for the
first time, were eligible for the study. Those who
had previously consulted another physician or
had been taking other medications were not ex-
cluded. Patients experiencing headaches for ≥ 15
days in 1 month (i.e. chronic daily headache) were
excluded from the study. The study project was
reviewed and approved by the Joint Institutional
Review Board in Taiwan. All patients were re-
quired to provide written informed consent before
entering the study.
Practice settings
The survey was conducted across 50 practice set-
tings in Taiwan. Study centers were classified as
(a) university-based hospitals or medical centers,
(b) community hospitals (catering to the local
community) and (c) solo practices.
Recent data reveal that Taiwan’s National
Health Insurance program, which was launched
in 1995, has recruited over 99% of the population
and 91% of healthcare providers.9 Unlike the US,
UK or Canada, there is no primary care system in
Taiwan and patients can access university-based
hospitals or medical centers as a first resort. Taiwan
also lacks a specialty referral system; therefore, only
4% of patients who consulted medical centers
were referrals.9
The current study investigated migraine diagno-
sis by targeting neurologists among different prac-
tice settings. In 2005, there were 553 board-certified
neurologists in Taiwan. The plan was to recruit as
many neurologists and patients as possible, until a
satisfactory number was reached (non-probability
sampling). For generalization, each neurologist
was restricted to interviewing 10 patients at most.
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Procedures
This cross-sectional survey involved two groups
of respondents: physicians and their patients. Two
sets of standardized questionnaires were designed,
based on the criteria of migraine proposed by
the ICHD-2.5 Participating physicians completed
the Physician’s Core Screening Questionnaire and
each patient completed the Patient Characteristics
Questionnaire.
Patient Characteristics Questionnaire
The Patient Characteristics Questionnaire consists
of 18 items that include demographics, educa-
tional status, employment status, migraine history,
duration and severity of headache, social disabil-
ity and headache symptoms. Headache intensity
was self-rated using the anchored horizontal 10-
cm visual analog scale (VAS) for pain, where re-
spondents were asked to rate on a scale of 0 to 10
how painful their worst headache was in the pre-
vious year. On this scale, 0 indicated No Pain,
and 10 represented Worst Pain Ever; 1, 2, 3 were
set as Mild Pain; 4, 5, 6 as Moderate Pain; and 7, 
8, 9, 10 as Severe Pain. In this study, some of the
items in the Patient Characteristics Question-
naire were used alone or in combination as the
screening tool for surveying migraine and the re-
sults were compared to the ICHD-2 diagnostic
criteria.
Physician’s Core Screening Questionnaire
The Physician’s Core Screening Questionnaire is
comprised of 12 items, including the patient’s
headache profile, disability levels and treatment
history. In the questionnaire, physicians were re-
quired to state whether the patient could be diag-
nosed with migraine or not. Patients’ headache
profiles obtained from the physicians’ question-
naires were tested for fit by a computer-based al-
gorithm against the diagnostic criteria of ICHD-2
for migraine (Table 1). In this study, ICHD-2 mi-
graine without aura (code 1.1) or migraine with aura
(code 1.2) were designated as “strict migraine”
and ICHD-2 migraine without aura, migraine with
aura or probable migraine (code 1.6) were desig-
nated as ‘‘any migraine”.
Statistical analysis
The ICHD-2 criteria were considered the gold
standard for migraine diagnosis in this study.
The proportions of patients fulfilling “strict mi-
graine” and “any migraine” were calculated and
compared with those from the physicians’ diag-
noses. The sensitivity, specificity, positive predic-
tive value (PPV), negative predictive value (NPV),
positive likelihood ratio (LR+) and negative like-
lihood ratio (LR−) of certain items in the patient’s
questionnaire, either alone or in combination,
were calculated to predict the diagnosis of mi-
graine. The odds ratios (ORs) of the items and
their 95% confidence intervals (CIs) were also cal-
culated. The kappa (κ) statistics and agreement
rates were calculated for the physician’s diagnosis
versus the ICHD-2-defined diagnosis of migraine.
Values of κ above 0.75 indicated excellent agree-
ment, while values between 0.75 and 0.40 indi-
cated moderate agreement, and those below 0.40
were considered to indicate poor agreement.10
Results
Physicians
Among the 119 participating physicians, 102 re-
cruited at least one patient. Physicians were pre-
dominantly male (82%) with an average age of
42 ± 7 years (range, 30–67 years), and six were pe-
diatric neurologists. Fifty-five physicians were prac-
ticing in university-based hospitals or medical
centers, 44 in community hospitals and three in
solo practices. Each physician recruited an average
of 8 ± 3 patients into the study.
Patients
Of the 846 completed questionnaires, 91 were ex-
cluded from the analysis. The reasons for exclusion
included patients reporting headache for > 15
days/month (n = 65) and incomplete data (n= 26).
Of the 755 enrolled patients, 358 (47%) needed
assistance to complete the questionnaire. Par-
ticipating patients were predominately female
(71%), with a mean age of 37 ± 15 years (range,
7–90 years). The majority (70%) of patients had 
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completed senior high-school education or higher.
About 55% of patients were currently employed.
Seventy-four (10%) patients claimed that head-
aches prevented them from being employed.
About half of the enrolled patients had a head-
ache history of more than 3 years. Four hundred
and two (53%) patients rated their headache in-
tensity as severe and 278 (37%) as moderate. In
contrast, only 70 (9%) patients reported that their
headaches were mild. The mean VAS was 6.6 ± 2
(range, 0–10). Among patients with severe inten-
sity headaches, 71% reported headache-related
disabilities in working, studying and housekeep-
ing, and 71% reported a disability that was signif-
icant enough to affect family, social life or leisure
activities. Only 37% of the patients with moder-
ate intensity headaches reported headache-related
disability that affected working, studying or house-
keeping, and 37% reported an effect on family,
social life or leisure activities.
Comparisons of migraine diagnoses by
physicians and ICHD-2 criteria
Of the 755 patients, 451 (60%) were diagnosed to
have migraine by physicians. The ICHD-2 criteria
for “strict migraine” and “any migraine” were ful-
filled for 48% (363/755) and 71% (537/755) of
patients, respectively (Table 2). Among the 363
patients with “strict migraine”, 243 (67%) were
diagnosed as having migraine without aura and
120 (33%) as having migraine with aura. Among
the 537 patients diagnosed as having “any mi-
graine” based on ICHD-2 criteria, 413 were iden-
tified by physicians and approximately 23%
S.J. Wang, et al
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Table 1. Current diagnostic criteria of migraine in the International Classification of Headache Disorders, 2nd
edition
Migraine without aura (1.1)
A. At least 5 attacks fulfilling criteria B–D
B. Headache attacks lasting 4–72 hours and occurring ≥ 15 days/month (untreated or unsuccessfully treated)
C. Headache has at least 2 of the following characteristics
– Unilateral location
– Pulsating quality
– Moderate or severe pain intensity
– Aggravated by or causing avoidance of routine physical activity (e.g. walking or climbing stairs)
D. During headache, there is at least 1 of the following
– Nausea and/or vomiting
– Photophobia and phonophobia
E. Not attributed to another disorder
Typical aura with migraine headache (1.2)
A. At least 2 attacks fulfilling criteria B–E
B. Fully reversible visual, sensory or speech symptoms but no motor weakness
C. At least 2 of the following
– Homonymous visual symptoms including positive features (e.g. flickering lights, spots or lines), and/or 
negative features (e.g. loss of vision), and/or unilateral sensory symptoms including positive features 
(e.g. pins and needles) and/or negative features (e.g. numbness)
– At least 1 symptom develops gradually over 55 minutes and/or different symptoms occur in succession
– Each symptom lasts for 5–60 minutes
D. Headache that meets criteria B–D for migraine without aura (1.1) begins during the aura or follows 
aura within 60 minutes
E. Not attributed to another disorder
Probable migraine without aura (1.6.1)
A. Attacks fulfilling all but 1 criteria from A–D for migraine without aura (1.1)
B. Not attributed to another disorder
(124/537) of patients were not diagnosed. Among
these 124 patients, 30 had migraine without aura,
10 had migraine with aura and 84 had probable mi-
graine (68%). Of the 174 patients with ICHD-2-
defined probable migraine, only 90 (52%) were
recognized as having migraine by physicians. As
for the remaining 218 patients without ICHD-2
“any migraine”, 38 were diagnosed by physicians
to have migraine (Table 3). The physicians tended
to diagnose migraine in those without ICHD-2
“any migraine” if their headaches were pulsatile
(OR = 4.54). Of note, in those with ICHD-2 “any
migraine”, patients with pulsatile headaches also
had the highest OR (6.91) to be diagnosed by
our physicians than those without. For “strict mi-
graine”, the level of overall agreement between
physicians’ diagnoses and ICHD-2 criteria was 78%
(κ = 0.558). Similarly, the level of overall agree-
ment between physicians’ diagnoses and ICHD-2
criteria of “any migraine” was 79% (κ = 0.532)
(Table 4).
Comparisons among different clinical
settings
We did not find any difference in patient head-
ache profile, frequencies of physician-diagnosed
migraine or ICHD-2 “any migraine” or “strict
migraine” in comparisons between university-
based hospitals and medical centers, community
hospitals and solo practices (data not shown).
Patient awareness of migraine versus
physician and ICHD-2 diagnoses
Of the 755 patients, 272 (36%) had been diag-
nosed to have migraine before this study. “Any
migraine” was confirmed in 225 (83%) of these
patients by ICHD-2 criteria and in 218 (80%) pa-
tients by our physicians. Nevertheless, 308 (41%)
patients diagnosed by ICHD-2 criteria with “any
migraine” this time had never previously been
diagnosed with migraine.
ORs of items in Patient Characteristics
Questionnaire
Logistic regression models for patients diagnosed
as having ICHD-2 “any migraine” revealed that
almost every item in univariate models was sig-
nificantly associated with migraine diagnosis
(Table 5). In comparison, moderate or severe
headache and nausea/vomiting had the highest
ORs followed by work/school/household disabil-
ity and photophobia. Nausea/vomiting had the
Diagnosis and development of screening items for migraine
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Table 2. Proportion of patients diagnosed with migraine by physicians and International Classification of
Headache Disorders, 2nd edition (ICHD-2)*
All patients 
Diagnosis of ICHD-2 strict ICHD-2 any 
(n = 755)
migraine by migraine migraine 
physician (n = 451) (n = 363) (n = 537)
Moderate or severe headache 532 (70.5) 353 (78.3) 320 (88.2) 444 (82.7)
Pulsatile 433 (57.4) 343 (76.1) 268 (73.8) 364 (67.8)
Nausea 406 (53.8) 327 (72.5) 309 (85.1) 380 (70.8)
Unilateral 373 (49.4) 265 (58.8) 226 (62.3) 301 (56.1)
Headache aggravated 364 (48.2) 270 (59.9) 235 (64.7) 320 (59.6)
by physical activities
Phonophobia 313 (41.5) 240 (53.2) 222 (61.2) 282 (52.5)
Vomiting 234 (31.0) 201 (44.6) 184 (50.7) 223 (41.5)
Photophobia 213 (28.3) 176 (39.0) 168 (46.3) 196 (36.5)
Headache lasting 4–72 hr 586 (77.6) 404 (89.6) 349 (96.1) 498 (92.7)
Headache-related disability in 413 (54.7) 296 (65.6) 246 (67.8) 348 (64.8)
studying, working or housekeeping
Headache-related disability in family, 395 (52.3) 281 (62.3) 235 (64.7) 329 (61.3)
social life or leisure activities
*Data presented as n (%).
best results regarding sensitivity, specificity, PPV,
NPV, LR+ and LR−.
Sensitivity and specificity of combinations 
of screening items
Empirically, the following variables were selected
for further analysis: work or school disability, so-
cial disability, nausea/vomiting, photophobia,
phonophobia, moderate or severe headache, se-
vere headache and physical activity aggravation.
We tested all combinations from any one to any
three for sensitivity, specificity, PPV, NPV, LR+ and
LR− to diagnose ICHD-2 “any migraine”. The op-
timal combination was achieved when any two
of the following three items were present: nausea/
vomiting, photophobia, and moderate or severe
headache. This three-item screen yielded a sensi-
tivity of 0.73, a specificity of 0.82, a PPV of 0.91,
LR+ of 4.06 and LR− of 0.33. In contrast, the next
best combination of nausea/vomiting, photopho-
bia, and work/school/household disability showed
a sensitivity of 0.56, a specificity of 0.88, a PPV
of 0.92, LR+ of 4.67 and LR− of 0.50.
Discussion
This study showed that, in Taiwan, migraine 
was the most common diagnostic entity for pa-
tients presenting with headache complaints to
S.J. Wang, et al
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Table 3. Proportion of any migraine patients diagnosed/not diagnosed by physicians*
Any migraine Not migraine 
Diagnosed by Not diagnosed Diagnosed by Not diagnosed
OR 
physician by physician 
OR 
physician by physician 
(95% CI)
(n = 413) (n = 124)
(95% CI)
(n = 38) (n = 180)
Moderate or 343 (83.1) 101 (81.5) 1.12 10 (26.3) 78 (43.3) 0.47 
severe headache (0.66–1.88) (0.21–1.02)
Pulsatile 322 (78.0) 42 (33.9) 6.91 21 (55.3) 48 (26.7) 3.40 
(4.46–10.71) (1.65–6.98)
Nausea 322 (78.0) 58 (46.8) 4.03 5 (13.2) 21 (11.7) 1.15 
(2.64–6.14) (0.40–3.26)
Unilateral 252 (61.0) 49 (39.5) 2.40 13 (34.2) 59 (32.8) 1.07 
(1.59–3.61) (0.51–2.23)
Headache 264 (63.9) 56 (45.2) 2.15 6 (15.8) 38 (21.1) 0.70 
aggravated by (1.43–3.23) (0.27–1.80)
physical activities
Phonophobia 236 (57.1) 46 (37.1) 2.26 4 (10.5) 27 (15.0) 0.67 
(1.50–3.42) (0.22–2.03)
Vomiting 197 (47.7) 26 (21.0) 3.44 4 (10.5) 7 (3.9) 2.91 
(2.14–5.52) (0.81–10.48)
Photophobia 172 (41.7) 24 (19.4) 2.97 4 (10.5) 13 (7.3) 1.50 
(1.83–4.84) (0.46–4.89)
Headache limited 284 (68.8) 64 (51.6) 2.10 12 (31.6) 53 (29.4) 1.09 
patient from (1.39–3.16) (0.51–2.32)
studying, working
or housekeeping
Headache limited 267 (64.7) 62 (50.0) 1.84 14 (36.8) 52 (28.9) 1.42 
patient from (1.23–2.76) (0.68–2.97)
family, social life 
or leisure activities
*Data presented as n (%). OR = odds ratio; CI = confidence interval.
neurological clinics and many patients had not
been diagnosed before. Approximately 71% of
patients fulfilled the ICHD-2 criteria for migraine
or probable migraine, while only 48% fulfilled
the criteria of ICHD-2 for “strict migraine”.
Notably, our neurologists’ diagnostic rate fell in
between (60%). In addition, kappa statistics re-
vealed a very similar level of agreement between
physicians’ diagnoses of migraine and “strict mi-
graine” or “any migraine”. If ICHD-2 criteria for
“any migraine” were considered, about 23% of
migraine sufferers failed to be diagnosed by phy-
sicians. This figure is in line with the results of the
Landmark Study,4 in which approximately one in
four patients was judged as not having migraine
by the physician and was subsequently diagnosed
with migraine by an expert panel applying ICHD-
2 criteria for migraine or probable migraine. We
found that the failure to recognize probable mi-
graine as one migraine spectrum was the major
reason for the under-diagnosis. Our study also
revealed that those erroneously diagnosed as 
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Table 5. Relationships of items in Patient Characteristics Questionnaire and the diagnosis of any migraine by International
Classification of Headache Disorders, 2nd edition
OR (95% CI) Sensitivity Specificity PPV NPV LR+ (95% CI) LR− (95% CI)
Headache limited 3.64 0.61 0.70 0.83 0.42 2.03 0.56 
patient from family, (2.59–5.10) (1.64–2.52) (0.08–3.95)
social life or leisure 
activities 
Headache limited 4.32 0.65 0.70 0.84 0.45 2.17 0.50 
patient from studying, (3.07–6.08) (1.75–2.68) (0.07–3.55)
working or housekeeping
Headache aggravated 3.05 0.56 0.71 0.83 0.39 1.93 0.62 
by physical activities (2.17–4.27) (1.55–2.41) (0.09–4.39)
Nausea/vomiting 12.96 0.67 0.86 0.92 0.52 4.79 0.38 
(8.47–19.84) (3.42–6.70) (0.05–2.72)
Photophobia 4.13 0.29 0.91 0.89 0.34 3.22 0.78 
(2.51–6.78) (2.08–5.00) (0.11–5.52)
Phonophobia 2.73 0.42 0.79 0.83 0.35 2.00 0.73 
(1.89–3.95) (1.51–2.64) (0.10–5.20)
Moderate or 13.54 0.97 0.27 0.77 0.80 1.33 0.11 
severe headache (7.36–24.92) (1.22–1.44) (0.01–0.84)
Severe headache 4.19 0.63 0.71 0.84 0.44 2.17 0.52 
(2.98–5.88) (1.75–2.70) (0.07–3.69)
OR = odds ratio; CI = confidence interval; PPV = positive predictive value; NPV = negative predictive value; LR+ = positive likelihood ratio; LR− = negative
likelihood ratio.
Table 4. Agreement in migraine diagnoses between International Classification of Headache Disorders, 
2nd edition (ICHD-2) and physicians*
ICHD-2 strict migraine† ICHD-2 any migraine‡
Yes No Total Yes No Total
Physician diagnosis of migraine
Yes 323 (43) 128 (17) 451 (60) 413 (55) 38 (5) 451 (60)
No 40 (5) 264 (35) 304 (40) 124 (16) 180 (24) 304 (40)
Total 363 (48) 392 (52) 755 (100) 537 (71) 218 (29) 755 (100)
*Data presented as n (%); †k = 0.558 (95% confidence interval, 0.509–0.616); ‡k = 0.532 (95% confidence interval, 0.471–0.594).
migraineurs were more likely to have pulsatile
headache, which is considered as a migraine trait
by most physicians in Taiwan.
Probable migraine was diagnosed if the head-
ache profile fulfilled all but one criterion for 
migraine with or without aura.5 A recent study
conducted in the U.S. showed that the epidemio-
logic profile of probable migraine was similar to
that of migraine and many patients with probable
migraine did not receive diagnosis and adequate
treatment.11 Our previous survey demonstrated
that including probable migraine into the mi-
graine spectrum could reflect the true disease bur-
den of migraine in a 3-year follow-up study on
adolescents.12 This current study showed that
probable migraine was very prevalent in the neu-
rological clinics in Taiwan. Most of the ICHD-2
“any migraine” patients (68%) who were not di-
agnosed with migraine actually had probable
migraine. Only one half of patients with proba-
ble migraine were diagnosed with migraine by our
participating physicians. Therefore, it is very im-
portant to educate physicians to recognize this
migraine subtype.
By analyzing the items of the Patient Char-
acteristics Questionnaire as screening tools for
ICHD-2 “any migraine,” we found nausea/vom-
iting to be the best single item that yielded the
most satisfactory levels of sensitivity (0.67), spec-
ificity (0.86) and PPV (0.92). This is because of the
diagnostic criteria of ICHD-2 migraine, in which
the presence of nausea/vomiting alone can fulfill
one diagnostic criterion. Of note, nausea/vomiting
should not be considered as a specific symptom
for migraine because several primary or secondary
headache disorders also present with these symp-
toms. A U.S.-based ID MigraineTM validation
study13 identified a three-item subset of disability,
nausea and photophobia as the optimal migraine
screener. Our study also found that two of the
following three items, i.e. nausea/vomiting, pho-
tophobia, and moderate or severe headache, best
predicted migraine diagnosis. These items were
very similar to those in the ID MigraineTM, except
that headache-related disability was replaced by
moderate or severe pain.13 This discrepancy might
be due to the fact that more than half of our pa-
tients did not report work or social disabilities
even when they had moderate headaches. This
difference may be related to a cultural discrep-
ancy in reporting headache disability between
Taiwanese and U.S. patients. Therefore, headache
intensity is more sensitive than headache-related
disability as a migraine screening item in Taiwan.
The strengths of this study are the large 
sample size of headache patients and the recruit-
ment of up to one fifth (18.4%) of board-certified
neurologists in Taiwan. Nevertheless, this study
did not find differences in migraine diagnoses
among patients in the different clinical settings of
university-based hospitals and medical centers,
community hospitals and solo practices. This is
because the majority of neurologists’ patients
were self-referred and their headache profile was
similar in different clinical settings. Therefore,
our study results can be generalized to all settings
of neurological practice in Taiwan. Nevertheless,
whether or not our results can be applied to other
specialties, such as family medicine or internal
medicine, needs further study.
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